Scrip
GSK may ramp up in India, says no to pure generics
09 March 2010
Anju Ghangurde
Please Login to read the full article.
09 March 2010
Anju Ghangurde
aghangurde@yahoo.com
GlaxoSmithKline intends to stay away from "pure generics" in Western markets, even as it outlined its intent to expand organically as well as through potential acquisitions in India.
GSK chief executive
Andrew Witty, who was in India to dedicate GSK's albendazole production line in Nashik...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
- Executive Briefing – Brazil emerges as a saviour for pharma
- Executive Briefing – Health technology assessment: a brief look at the EU
COMMENT
Other Informa Comment
